Skip to main content

Table 2 Cardiac magnetic resonance characteristics of subjects

From: Hemoglobin A1c in type 2 diabetes mellitus patients with preserved ejection fraction is an independent predictor of left ventricular myocardial deformation and tissue abnormalities

 

Cs (n = 44)

T2DM (n = 38)

G1 (n = 19)

G2 (n = 19)

HT (n = 32)

LVM/g

79.05 (64.67, 101.61)

117.05 (87.84, 172.50)a

95.60 (79.90, 172.50)

130.17 (88.80, 217.23)a

120.00 (94.27, 141.77)a

LVM index/(g/m2)

49.26 (39.85, 58.00)

62.68 (48.92, 88.77)a

54.32 (44.95, 91.41)a

68.79 (50.12, 96.97)a

67.30 (56.62, 77.87)a

LVEDV/ml

129.45 (109.47, 144.42)

136.68 (108.49, 167.64)a

135.30 (105.30, 148.51)

159.50 (123.65, 178.23)a

130.84 (110.95, 150.47)

LVESV/ml

52.76 (41.80, 63.12)

47.74 (33.42, 72.50)

43.80 (30.05, 59.66)

55.65 (33.73, 91.61)

49.70 (42.75, 64.30)

LVSV/ml

77.41 ± 15.00

90.22 ± 28.96a

89.00 ± 34.75

91.38 ± 23.19a

79.57 ± 19.66

LVEDVi/(ml/m2)

75.55 (68.62, 82.75)

75.65 (65.85, 83.88)

71.61 (65.85, 81.54)

78.93 (63.26, 95.42)

71.70 (60.82, 84.75)

LVESVi/(ml/m2)

31.25 (26.60, 35.60)

27.50 (18.66, 39.77)

26.63 (17.42, 36.04)

30.23 (18.78, 44.90)

26.90 (19.65, 33.11)

LVSVi/ (ml/m2)

45.98 ± 9.46

48.37 ± 13.45

48.77 ± 15.20

47.99 ± 12.00

43.52 ± 10.29

LVEF/%

60.27 ± 6.21

61.77 ± 13.69

63.25 ± 13.85

60.38 ± 13.79

61.15 ± 10.47

LVGRS/%

33.15 ± 8.01

32.41 ± 6.00

32.60 ± 6.75

32.22 ± 5.36

32.37 ± 4.56

LVGCS/%

−23.74 ± 3.31

−23.24 ± 3.25

−23.14 ± 3.01

−23.34 ± 3.49

−22.66 ± 3.00

LVGLS/%

−19.66 ± 3.21

−16.51 ± 2.52a

−17.27 ± 2.57a

−15.75 ± 2.29a, b

−17.54 ± 3.09a, c

Apex native T1/ms

1027.53 ± 33.58

1027.36 ± 48.08

1025.00 ± 55.34

1029.87 ± 40.65

1025.28 ± 48.97

Mid native T1/ms

1031.54 ± 28.96

1052.26 ± 39.67a

1046.70 ± 47.89

1057.82 ± 29.77a

1060.90 ± 41.37a

Base native T1/ms

1037.00 ± 26.35

1062.78 ± 44.08a

1067.56 ± 55.63

1058.00 ± 29.53a

1070.31 ± 42.00a

Global native T1/ms

1035.02 ± 26.65

1060.17 ± 43.63a

1051.64 ± 46.65

1068.70 ± 39.93a

1059.46 ± 34.74a

Apex post contrast T1/ms

446.65 ± 61.12

443.30 ± 51.47

443.05 ± 62.06

443.56 ± 39.29

439.40 ± 58.76

Mid post contrast T1/ms

460.47 ± 58.28

453.76 ± 45.07

456.23 ± 50.98

451.29 ± 39.71

458.87 ± 58.74

Base post contrast T1/ms

465.84 ± 58.20

457.50 ± 50.20

462.31 ± 57.62

452.68 ± 42.87

459.28 ± 58.55

Global post contrast T1/ms

456.25 ± 59.64

446.50 ± 41.14

452.29 ± 47.12

440.70 ± 34.63

438.03 ± 67.95

Apex ECV/%

26.60 ± 2.63

28.76 ± 2.10a

28.81 ± 2.46a

28.71 ± 1.77a

27.76 ± 2.49

Mid ECV/%

25.78 ± 2.35

29.70 ± 3.18a

28.99 ± 3.78a

30.41 ± 2.35a, b

28.12 ± 2.03a, c

Base ECV/%

25.93 ± 2.43

30.03 ± 3.30a

28.43 ± 3.33a

31.63 ± 2.44a, b

28.53 ± 2.48a, c

Global ECV/%

26.33 ± 2.81

30.75 ± 3.65a

29.59 ± 3.90a

31.92 ± 3.05a, b

29.22 ± 6.58a, c

  1. LVM  left ventricular mass, LVEDV  left ventricular end diastolic volume, LVESV  left ventricular end systolic volume, LVSV  left ventricular stroke volume, LVEDVi  left ventricular end diastolic volume index, LVESVi  left ventricular end systolic volume index, LVSVi  left ventricular stroke volume index, LVEF  left ventricular ejection fraction, LVGLS  left ventricular global longitudinal strain, LVGRS  left ventricular global radial strain, LVGCS  left ventricular global circumferential strain, ECV  extracellular volume fraction
  2. All results shown as percent, Mean ± SD or median (25th, 75th percentiles)
  3. ap value versus Cs, p < 0.05
  4. bp value versus G1, p < 0.05
  5. cp value G2, p < 0.05
  6. p < 0.05 is considered to indicate statistical significance